Pharmacology, Toxicology and Biochemistry Department, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt.
Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Int J Biol Macromol. 2024 Oct;278(Pt 1):134688. doi: 10.1016/j.ijbiomac.2024.134688. Epub 2024 Aug 11.
CircRNAs have been increasingly appreciated as modulators of osteoporosis. This study investigated the expression of circ-0091579 and circ-HIPK3 in PBMCs of postmenopausal women with osteopenia and osteoporosis, aiming to underline their molecular mechanisms involved in pathogenesis of the disease. Seventy patients were stratified into two groups: 35 with osteopenia and 35 with osteoporosis, along with 30 healthy controls. Expressions of circ-0091579 and circ-HIPK3, miR-1225-5p and miR-338-3p, together with NF-κB, were assessed using RT-PCR. Keap1, Nrf2, and MAFB were determined using Western blot, while RANKL, OPG, IL-1β, and IL-6 were measured by ELISA. GSH and MDA were estimated colorimetrically. Data revealed that circ-0091579 was markedly upregulated, whereas miR-1225-5p was downregulated in patients relative to controls. Additionally, circ-HIPK3 was significantly decreased, while miR-338-3p was increased in the diseased groups. Circ-0091579 was directly correlated with RANKL/OPG, NF-κB, IL-1β, IL-6 and MDA, while inversely correlated with miR-1225-5p, T-score, BMD and GSH. Meanwhile, circ-HIPK3 and miR-338-3p were interrelated in an opposite manner. Eventually, the interplay among these downstream players induced an imbalance in bone homeostasis, triggering osteoporosis. Notably, these circRNAs differentiated patients from controls and those with osteopenia from osteoporotic ones. Thus, they could serve as biomarkers for early detection and tracking of osteoporosis.
CircRNAs 已被越来越多地认为是骨质疏松症的调节剂。本研究旨在研究 circ-0091579 和 circ-HIPK3 在绝经后妇女骨质疏松症患者 PBMCs 中的表达,以强调它们在疾病发病机制中涉及的分子机制。将 70 名患者分为两组:35 名骨质疏松症患者和 35 名骨质疏松症患者,以及 30 名健康对照者。使用 RT-PCR 评估 circ-0091579 和 circ-HIPK3、miR-1225-5p 和 miR-338-3p 的表达,使用 Western blot 测定 Keap1、Nrf2 和 MAFB,通过 ELISA 测定 RANKL、OPG、IL-1β 和 IL-6。使用比色法测定 GSH 和 MDA。数据显示,与对照组相比,患者的 circ-0091579 明显上调,而 miR-1225-5p 下调。此外,疾病组中的 circ-HIPK3 显著降低,而 miR-338-3p 增加。circ-0091579 与 RANKL/OPG、NF-κB、IL-1β、IL-6 和 MDA 直接相关,与 miR-1225-5p、T 评分、BMD 和 GSH 呈负相关。同时,circ-HIPK3 和 miR-338-3p 以相反的方式相互关联。最终,这些下游参与者之间的相互作用导致骨稳态失衡,引发骨质疏松症。值得注意的是,这些 circRNAs 将患者与对照组以及骨质疏松症患者与骨质疏松症患者区分开来。因此,它们可以作为骨质疏松症早期检测和跟踪的生物标志物。